cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock
YCBD.PRA
YCBD.PRA was delisted on the 5th of May, 2025.
0 hedge funds and large institutions have $0 invested in cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock in 2025 Q2 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 6 closing their positions.
100% less funds holding
Funds holding: 6 → 0 (-6)
100% less capital invested
Capital invested by funds: $493K → $0 (-$493K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 6
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MG
Marex Group
London,
|
-$222K |
| 2 |
CL
CSS LLC
Chicago,
Illinois
|
-$101K |
| 3 |
CD
Chapin Davis
Baltimore,
Maryland
|
-$98.5K |
| 4 |
AA
Alesco Advisors
Pittsford,
New York
|
-$56.4K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$14K |
YCBD.PRA Hedge Fund Activity: Q2 2025 in Review
0 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock (YCBD.PRA) for Q2 2025, worth a combined $0 — down 100% from $493K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of YCBD.PRA and 0 opened new positions — a net loss of 6 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Marex Group, exiting entirely with an estimated $222K sold.
- 0 institutional investors held cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock (YCBD.PRA) as of Q2 2025, down from 6 in Q1 2025.
- Funds reported $0 of cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock stock for Q2 2025, down 100% quarter-over-quarter.
- 0 funds opened new cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock positions in Q2 2025 and 6 closed out, a net change of -6 holders.
- The largest cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock seller in Q2 2025 was Marex Group, an estimated $222K sold.
Based on aggregated 13F filings for Q2 2025.